Home
Charts
Search
Watchlist
Products
All IPOs
₹63 - 63
Sheel Biotech Ltd
MiscellaneousIPOSME
₹63 - 63
Our Company is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. We manufacture and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). Additionally, we deliver green landscaping services to both government and private sectors.
Lot2,000Min Invest₹2,52,000Face Value₹10Issue Size₹34 CrFresh Issue₹34 CrListing Price₹91CMP₹59
Timeline
30 Sept
Bidding opens
3 Oct
Bidding closes
6 Oct
Allotment
7 Oct
Refund & demat credit
8 Oct
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹34 Cr0.54 Cr shares
Fresh Issue₹34 Cr
Face Value₹10
Lot Size2,000 shares
ReservationQIB 49.73% · NII 15.09% · RETAIL 35.18%
Application Sizes
Retail₹2,52,0001-1 lots
sNII₹2,52,000from 2 lots
bNII₹10,08,000from 8 lots
Managers & Registrar
Lead ManagerNarnolia Financial Services Ltd
RegistrarSkyline Financial Services Pvt
Ownership & Proceeds
Shareholding
CategoryPre IPOPost IPOPromoter Group96.98%71.25%Public3.02%28.75%
Objects of the Issue
- Capital expenditure requirements
- Working capital requirement
- General corporate purposes
Financials
Profit & Loss
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| RevenueCr | 71 | 80 | 92 | 102 | 110 |
| Operating ProfitCr | 6 | 9 | 14 | 15 | 16 |
| OPM% | 9.0 | 11.0 | 15.7 | 14.7 | 14.8 |
| PBTCr | 5 | 6 | 12 | 13 | 14 |
| PATCr | 5 | 5 | 10 | 11 | 12 |
| EPS | 3 | 4 | 7 | 7 | 7 |
Balance Sheet
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity CapitalCr | 4 | 4 | 4 | 15 | - |
| ReservesCr | 56 | 59 | 69 | 69 | - |
| BorrowingsCr | 24 | 19 | 24 | 17 | - |
| Total AssetsCr | 93 | 94 | 106 | 113 | - |
Cash Flow
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash FlowCr | 2 | 9 | -1 | 9 | -18 |
| Investing Cash FlowCr | -2 | -2 | 0 | -2 | -7 |
| Financing Cash FlowCr | 0 | -7 | 2 | -7 | 26 |
| Net Cash FlowCr | 0 | 0 | 0 | 0 | 2 |
Strengths & Risks
Strengths · as stated in the DRHP
- Our ability to capitalize the opportunities and growth in the Tissue Culture industry.
- Promotion of Tissue Culture industry by the Government of India.
- Cordial relations with our clients.
Strategies · as stated in the DRHP
- Collaboration with Dutch technology.
- Northern Region 2nd biggest tissue culture lab.
- Dedicated team for procuring government tenders.
- Green house facilities which protects the plants from hardening.
Risks · as stated in the DRHP
- The company depends on government tenders for its revenue of operations. Any unavailability or any failures to secure these tenders in the future may adversely affect the company's business operations and financial conditions.
- One of the company's business segment Tissue culture demands the highest level of precautions in quality, storage, and temperature management. Any negligence in these areas can significantly affect its business outcomes.
- The company uses the proper techniques in the whole tissue culture process. Any Ineffective sterilization of tools and media can lead to contamination, which would adversely affect the entire culture.
- The company's business is subject to seasonal fluctuations that could result in delays or disruptions to its operations during the critical periods of the company's projects and cause severe damage to its premises and equipments.
- The Company is involved in certain legal proceedings/litigations. Any adverse decision in such proceedings may render us/them liable to penalties and may adversely affect ist business and result of operations.
- The company's success depends largely upon the services of its Directors, Promoters and other Key Managerial Personnel and the company's ability to attract and retain them. Demand for Key Managerial Personnel in the industry is intense and its inability to attract and retain Key Managerial Personnel may affect the operations of the Company.